Adam del Corral

Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

Richard M. Stone, Thomas Fischer, Ron Paquette et al. · Leukemia · 2012 · 273 citations · Full text

Medicine, Hematology, Oncology +13

Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2022 · 125 citations

Medicine, Oncology, Pharmacology +16

Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers

Adam del Corral, Catherine Dutreix, Alice Huntsman-Labed et al. · Cancer Chemotherapy and Pharmacology · 2012 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15